Effects of using both e-cigarettes and traditional cigarettes on heart health
Cardiovascular Effects of Inhalable Tobacco Product Dual Use
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10946632
This study looks at how using both e-cigarettes and regular cigarettes together can affect your heart and blood vessels, helping us understand the risks so we can better inform people about the dangers of using both types of tobacco.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10946632 on ClinicalTrials.gov |
What this research studies
This research investigates how the combined use of e-cigarettes and traditional cigarettes affects cardiovascular health. It examines the toxic effects of these inhalable tobacco products on blood vessels and heart function, utilizing both human and animal models. The study aims to identify the specific harmful components of these products and their impact on inflammation and vascular health. By understanding these effects, the research seeks to inform regulatory bodies about the risks associated with dual use of tobacco products.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use both e-cigarettes and traditional cigarettes.
Not a fit: Patients who do not use any form of tobacco or have pre-existing severe cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of cardiovascular diseases linked to tobacco product use.
How similar studies have performed: Previous research has indicated that both e-cigarettes and traditional cigarettes can have harmful cardiovascular effects, suggesting that this study builds on established findings.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SPRINGER, MATTHEW LAWRENCE — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: SPRINGER, MATTHEW LAWRENCE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.